Bis((R)-4-methyl-4,5-dihydrooxazol-2-yl)methane, 97%, 100mg

4,4-Difluorocyclohexanecarboxamide, 95.0%, 5g

1-Acetyl-N-methylpiperidin-4-amine, 97.0%, 5g

5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 95.0%, 5g

7-amino-5-(3,4-dimethoxyphenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile, 1g

3-Chloro-N-isopropylaniline, 95%, 1g

(2S,4S)-1-(tert-Butoxycarbonyl)-4-cyanopyrrolidine-2-carboxylic acid, 95.0%, 250mg

Sodium iodide, min. 99.5%, pa, ACS, 250 g, plastic packaging.

(E)-ETHYL 3-(2-FLUORO-5-NITROPHENYL)ACRYLATE, 95.0%, 100mg

5-Bromo-2-fluorocinnamic acid, 98.0%, 100g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)butanoic acid, 97%, 5g

4-Bromo-2-fluoropyridine, 98.0%, 100g

Gelsemin hydrochloride, 90%, 500 mg, glass packaging